Clinical trial
The Effect of Skin Antisepsis After Primary Skin Closure on the Incidence of Surgical Site Infection After Abdominal Surgery for Sepsis: a Preliminary Report of a Randomized Controlled Trial
NCT05896462 is registered in ClinicalTrials.gov with Ikechukwu Bartholomew Ulasi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Skin Antisepsis After Primary Skin Closure on the Incidence of Surgical Site Infection After Abdominal Surgery for Sepsis: a Preliminary Report of a Randomized Controlled Trial
- Lead sponsor
- Ikechukwu Bartholomew Ulasi
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 19, 2019
- Completion date
- March 29, 2022
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antisepsis